ELTS Score (EUTOS Long-Term Survival)
ورودیهای بالینی بیمار
حداقل ۱۵ — حداکثر ۱۰۰ • واحد: years
حداقل ۰ — حداکثر ۴۰ • واحد: cm
حداقل ۰ — حداکثر ۱۰۰ • واحد: %
حداقل ۱۰ — حداکثر ۳۰۰۰ • واحد: x10^9/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- low≤ 1.568
- intermediate1.568–2.2185
- high≥ 2.2185
The ELTS Score (EUTOS Long-Term Survival) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include age years. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
CML long-term survival risk score.
Clinical Indication
The ELTS Score (EUTOS Long-Term Survival) is indicated for bedside clinical practice to support CML long-term survival risk score.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.
Limitations & Contraindications
Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.
Clinical Pearls & Action Plan
Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.
ELTS = 0.0025x(age/10)^3 + 0.0615xspleen + 0.1052xblasts + 0.4104x(platelets/1000)^-0.5
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_years | integer | Yes | Age(years) |
| spleen_cm | float | Yes | Spleen size below costal margin(cm) |
| blasts_percent | float | Yes | Peripheral blood blasts(%) |
| platelets_x1e9_l | float | Yes | Platelets(x10^9/L) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| ≤ 1.568 | low | Low risk |
| 1.568–2.2185 | intermediate | Intermediate risk |
| ≥ 2.2185 | high | High risk |
Evidence-Based References (EBM)
- Pfirrmann M, et al. Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia. Leukemia. 2016;30(1):48-56.